Congress quietly expands permanent tax breaks for corporations and real estate investors
S. 2056 — CREATE JOBS Act · Filed by Ted Cruz (R-TX) · Introduced Jun 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill makes three major changes to business tax law: (1) it allows companies to immediately deduct 100% of the cost of equipment and property purchases instead of spreading the deduction over many years; (2) it adjusts depreciation deductions for real estate to account for inflation using a GDP deflator formula; and (3) it eliminates the requirement that research and development costs be amortized over 60 months, allowing them to be deducted immediately or amortized at the company's choice. The primary beneficiaries are corporations and businesses with significant capital investments, R&D spending, and real estate holdings.
Why we flagged it
The bill's core function is to accelerate business tax deductions—allowing immediate expensing of capital purchases and R&D costs rather than spreading them over time. This is a straightforward corporate tax benefit, not a jobs program in the traditional sense, despite the acronym's framing.
What the text implies
- The 'neutral cost recovery ratio' formula in Section 3 uses GDP deflator adjustments that may create unintended tax benefits for real estate investors during inflationary periods, as the 1.03 multiplier compounds annually and the ratio can never fall below 1.0, effectively guaranteeing real estate owners a minimum inflation-adjusted deduction regardless of actual property depreciation.
- Elimination of the 60-month amortization requirement for R&D (Section 4) may disproportionately benefit large, profitable corporations with immediate cash flow to absorb upfront deductions, while smaller startups with losses may see reduced benefit from the R&D credit carve-out in Section 280C.
The full analysis lists 4 implications of this text.
Who stands to gain
large corporations with significant capital expenditures; real estate investment trusts (REITs); technology and pharmaceutical companies with high R&D spending